$10.83
-0.02-0.18%
al cierre: -
$10.83
N/A
After hour: 4:42 PM EDT
Comments
Loading...
Ocular Therapeutix Actividad de operaciones con información privilegiada
OCULNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Ocular Therapeutix. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Ocular Therapeutix.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Ocular Therapeutix Inc los iniciados?
En Ocular Therapeutix Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de 25.87K acciones por valor de $277.79K, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El septiembre 4, 2025, Donald Notman, la empresa SEE REMARKS sold 1.07K acciones por $12.43 cada una.
- El agosto 27, 2025, Sanjay Nayak, la empresa CHIEF STRATEGY OFFICER sold 1.89K acciones por $12.04 cada una.
- El agosto 27, 2025, Peter Kaiser, la empresa CHIEF DEVELOPMENT OFFICER sold 3.01K acciones por $12.04 cada una.
Estadísticas de propiedad de Ocular Therapeutix Inc
Acciones en circulación
213.047M
Acciones en manos de personas con información privilegiada
7.971M
Porcentaje de acciones en manos de personas con información privilegiada
3.76%
Acciones en manos de instituciones
65.890M
Porcentaje de acciones en manos de instituciones
30.9%
Nov 07, 2025 | CHIEF BUSINESS OFFICER | -25.86K | $10.74 | -$277.79K | SELL | -12.93% | 174.13K | Nov 05 | ||
Oct 10, 2025 | CHIEF LEGAL OFFICER | -11.13K | $12.34 | -$137.37K | SELL | -11.28% | 87.57K | Oct 08 | ||
Oct 06, 2025 | CHIEF DEVELOPMENT OFFICER | -9.65K | $11.03 | -$106.47K | SELL | -4.73% | 194.44K | Oct 02 | ||
Oct 06, 2025 | CHIEF SCIENTIFIC OFFICER | -10.50K | $11.04 | -$115.94K | SELL | -4.04% | 249.41K | Oct 02 | ||
Sep 04, 2025 | SEE REMARKS | -1.07K | $12.43 | -$13.25K | SELL | -0.34% | 308.81K | Sep 02 | ||
Aug 27, 2025 | CHIEF DEVELOPMENT OFFICER | -3.01K | $12.04 | -$36.25K | SELL | -1.45% | 204.09K | Aug 25 | ||
Aug 27, 2025 | CHIEF STRATEGY OFFICER | -1.89K | $12.04 | -$22.70K | SELL | -0.67% | 279.74K | Aug 25 | ||
Aug 27, 2025 | CHIEF SCIENTIFIC OFFICER | -3.06K | $12.04 | -$36.88K | SELL | -1.16% | 259.91K | Aug 25 | ||
Aug 27, 2025 | SEE REMARKS | -21.49K | $12.04 | -$258.79K | SELL | -0.61% | 3.48M | Aug 25 | ||
Jun 03, 2025 | CHIEF MEDICAL OFFICER | -13.86K | $8.05 | -$111.58K | SELL | -6.28% | 206.81K | Jun 02 | ||
May 27, 2025 | CHIEF STRATEGY OFFICER | -1.86K | $7.17 | -$13.35K | SELL | -0.66% | 281.62K | May 23 | ||
May 27, 2025 | CHIEF DEVELOPMENT OFFICER | -2.97K | $7.17 | -$21.32K | SELL | -1.42% | 207.10K | May 23 | ||
May 27, 2025 | CHIEF SCIENTIFIC OFFICER | -3.02K | $7.18 | -$21.71K | SELL | -1.14% | 262.97K | May 23 | ||
May 27, 2025 | SEE REMARKS | -21.22K | $7.18 | -$152.35K | SELL | -0.60% | 3.50M | May 23 | ||
May 12, 2025 | DIRECTOR | 10.00K | $6.96 | $69.60K | BUY | 6.15% | 172.70K | May 08 | ||
Feb 26, 2025 | SEE REMARKS | -21.48K | $6.87 | -$147.53K | SELL | -0.61% | 3.52M | Feb 24 | ||
Feb 26, 2025 | CHIEF SCIENTIFIC OFFICER | -3.06K | $6.87 | -$21.03K | SELL | -1.14% | 266.00K | Feb 24 | ||
Feb 26, 2025 | CHIEF DEVELOPMENT OFFICER | -3.01K | $6.87 | -$20.67K | SELL | -1.41% | 210.08K | Feb 24 | ||
Feb 26, 2025 | CHIEF STRATEGY OFFICER | -1.90K | $6.84 | -$12.96K | SELL | -0.66% | 283.49K | Feb 24 | ||
Feb 04, 2025 | SEE REMARKS | -17.42K | $7.82 | -$136.24K | SELL | -8.26% | 193.44K | Jan 31 - Feb 04 | ||
Nov 27, 2024 | CHIEF SCIENTIFIC OFFICER | -2.95K | $9.01 | -$26.56K | SELL | -1.08% | 269.06K | Nov 25 | ||
Nov 27, 2024 | CHIEF DEVELOPMENT OFFICER | -2.90K | $9.01 | -$26.10K | SELL | -1.34% | 213.09K | Nov 25 | ||
Nov 27, 2024 | CHIEF STRATEGY OFFICER | -1.81K | $9.00 | -$16.33K | SELL | -1.03% | 174.38K | Nov 25 | ||
Nov 27, 2024 | SEE REMARKS | -20.68K | $9.01 | -$186.33K | SELL | -2.55% | 791.79K | Nov 25 | ||
Aug 27, 2024 | CHIEF STRATEGY OFFICER | -1.83K | $9.02 | -$16.52K | SELL | -1.03% | 176.19K | Aug 23 | ||
Aug 27, 2024 | SEE REMARKS | -20.88K | $9.02 | -$188.34K | SELL | -2.51% | 812.47K | Aug 23 | ||
May 28, 2024 | CHIEF STRATEGY OFFICER | -2.27K | $5.84 | -$13.28K | SELL | -1.26% | 178.03K | May 23 | ||
May 28, 2024 | SEE REMARKS | -21.63K | $5.79 | -$125.21K | SELL | -2.53% | 833.35K | May 23 | ||
Feb 27, 2024 | — | 930.85K | $7.52 | $7.00M | BUY | 12.15% | 8.59M | Feb 26 | ||
Feb 06, 2024 | CHIEF BUSINESS OFFICER | 45.89K | $4.86 | $28.72K | GRANT | 58.99% | 123.69K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | GENERAL COUNSEL | 64.33K | $4.86 | $29.30K | GRANT | 66.21% | 161.49K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | CHIEF MEDICAL OFFICER | 72.98K | $4.86 | $30.84K | GRANT | 91.14% | 153.05K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | CHIEF FINANCIAL OFFICER | 67.85K | $4.86 | $30.19K | GRANT | 53.21% | 195.36K | Feb 03 - Feb 05 | ||
Feb 06, 2024 | PRESIDENT AND CEO | 200.04K | $4.86 | $95.46K | GRANT | 50.62% | 595.20K | Feb 03 - Feb 05 | ||
Feb 02, 2024 | CHIEF FINANCIAL OFFICER | -6.43K | $4.95 | -$31.84K | SELL | -4.40% | 139.93K | Jan 31 | ||
Feb 02, 2024 | CHIEF MEDICAL OFFICER | -7.76K | $4.95 | -$38.43K | SELL | -7.72% | 92.77K | Jan 31 | ||
Feb 02, 2024 | GENERAL COUNSEL | -6.83K | $4.95 | -$33.81K | SELL | -5.89% | 109.22K | Jan 31 | ||
Feb 02, 2024 | CHIEF BUSINESS OFFICER | -5.15K | $4.95 | -$25.48K | SELL | -5.43% | 89.62K | Jan 31 | ||
Feb 02, 2024 | PRESIDENT AND CEO | -18.34K | $4.95 | -$90.77K | SELL | -4.05% | 434.44K | Jan 31 | ||
Dec 18, 2023 | — | 1.54M | $3.25 | $5.00M | BUY | 25.13% | 7.66M | Dec 14 | ||
Sep 05, 2023 | PRESIDENT AND CEO | 6.50K | $3.81 | $24.77K | BUY | 1.46% | 452.78K | Aug 30 | ||
Jul 11, 2023 | CHIEF MEDICAL OFFICER | -832.00 | $4.93 | -$4.10K | SELL | -0.82% | 100.53K | Jul 07 | ||
Feb 08, 2023 | CHIEF BUSINESS OFFICER | -5.83K | $4.24 | -$24.71K | SELL | -5.79% | 94.77K | Feb 06 | ||
Feb 08, 2023 | CHIEF MEDICAL OFFICER | -6.42K | $4.24 | -$27.20K | SELL | -5.95% | 101.36K | Feb 06 | ||
Feb 08, 2023 | CHIEF FINANCIAL OFFICER | -6.48K | $4.24 | -$27.46K | SELL | -4.44% | 139.39K | Feb 06 | ||
Feb 08, 2023 | GENERAL COUNSEL | -6.18K | $4.24 | -$26.21K | SELL | -5.36% | 109.07K | Feb 06 | ||
Feb 08, 2023 | PRESIDENT AND CEO | -19.67K | $4.24 | -$83.40K | SELL | -4.22% | 446.28K | Feb 06 | ||
Nov 09, 2022 | 10% OWNER | 7.33K | $3.50 | $25.65K | BUY | 0.12% | 6.12M | Nov 07 | ||
Oct 12, 2022 | 10% OWNER | 20.00K | $3.95 | $78.97K | BUY | 0.33% | 6.11M | Oct 10 - Oct 11 | ||
Sep 29, 2022 | 10% OWNER | 150.00K | $4.59 | $689.23K | BUY | 2.52% | 6.09M | Sep 27 - Sep 29 | ||
May 16, 2022 | DIRECTOR | 15.00K | $3.05 | $45.75K | BUY | 62.50% | 39.00K | May 12 | ||
Feb 23, 2022 | 10% OWNER | 50.00K | $4.96 | $247.93K | BUY | 0.85% | 5.94M | Feb 18 - Feb 23 | ||
Jan 31, 2022 | 10% OWNER | 5.50K | $5.20 | $28.60K | BUY | 0.09% | 5.89M | Jan 27 - Jan 28 | ||
Jan 24, 2022 | 10% OWNER | 74.50K | $5.45 | $405.81K | BUY | 1.28% | 5.89M | Jan 20 - Jan 24 | ||
Jan 18, 2022 | 10% OWNER | 50.00K | $6.06 | $302.92K | BUY | 0.87% | 5.81M | Jan 13 - Jan 18 | ||
Dec 16, 2021 | 10% OWNER | 44.49K | $6.35 | $282.42K | BUY | 0.78% | 5.76M | Dec 14 - Dec 15 | ||
Dec 14, 2021 | 10% OWNER | 40.51K | $6.61 | $267.80K | BUY | 0.71% | 5.72M | Dec 10 - Dec 13 | ||
Dec 08, 2021 | 10% OWNER | 60.90K | $6.18 | $376.60K | BUY | 1.08% | 5.68M | Dec 06 - Dec 08 | ||
Aug 24, 2021 | PRESIDENT AND CEO | 5.00K | $9.89 | $49.45K | BUY | 5.11% | 102.90K | Aug 20 | ||
May 21, 2021 | DIRECTOR | -10.00K | $14.30 | -$143.00K | SELL | -10.00% | 90.00K | May 20 | ||
Dec 07, 2020 | — | 0.00 | $5.09 | $127.18K | OPTION EXERCISE | 0.00% | 0.00 | Dec 03 | ||
Oct 20, 2020 | — | 437.00 | $10.48 | $4.58K | PURCHASE | 0.01% | 5.62M | Oct 16 | ||
May 21, 2020 | — | 363.64K | $5.50 | $2.00M | PURCHASE | 6.92% | 5.62M | May 19 | ||
Mar 24, 2020 | — | 109.10K | $4.71 | $514.20K | PURCHASE | 2.12% | 5.25M | Mar 20 - Mar 24 | ||
Mar 20, 2020 | — | 385.84K | $4.62 | $1.78M | PURCHASE | 8.11% | 5.15M | Mar 18 - Mar 19 | ||
Mar 17, 2020 | — | 955.06K | $4.55 | $4.35M | PURCHASE | 25.10% | 4.76M | Mar 13 - Mar 17 | ||
Jan 03, 2020 | — | 15.00K | $3.90 | $58.51K | PURCHASE | 0.31% | 4.92M | Jan 02 | ||
Jan 02, 2020 | — | 20.00K | $3.97 | $79.41K | PURCHASE | 10.67% | 207.50K | Dec 30 | ||
Jun 17, 2019 | CHIEF FINANCIAL OFFICER | 2.50K | $4.33 | $10.82K | BUY | 11.60% | 24.05K | Jun 14 | ||
Jun 17, 2019 | DIRECTOR | 4.50K | $4.40 | $19.80K | BUY | ∞ | 4.50K | Jun 14 | ||
Jun 10, 2019 | CHAIRMAN THE BOARD | 124.47K | $2.92 | $362.91K | BUY | 11.10% | 1.25M | Jun 06 - Jun 07 | ||
Jun 10, 2019 | PRESIDENT & CEO | 40.00K | $2.81 | $112.40K | BUY | 69.08% | 97.90K | Jun 06 | ||
Jun 06, 2019 | CHAIRMAN THE BOARD | 45.78K | $2.91 | $133.35K | BUY | 4.26% | 1.12M | Jun 04 - Jun 05 | ||
May 30, 2019 | CHIEF MEDICAL OFFICER | 12.00K | $2.51 | $30.12K | BUY | 87.68% | 25.69K | May 28 | ||
Mar 18, 2019 | DIRECTOR | 24.00K | $4.15 | $99.60K | BUY | ∞ | 24.00K | Mar 15 | ||
Mar 18, 2019 | CHIEF MEDICAL OFFICER | 10.00K | $4.15 | $41.50K | BUY | 271.30% | 13.69K | Mar 15 | ||
Mar 14, 2019 | DIRECTOR | 56.44K | $4.33 | $244.39K | BUY | 129.57% | 100.00K | Mar 13 | ||
Dec 18, 2018 | SEE REMARKS | 10.00K | $5.50 | $55.00K | BUY | 100.00% | 20.00K | Dec 14 | ||
Dec 12, 2018 | SEE REMARKS | 10.00K | $5.60 | $56.00K | BUY | ∞ | 10.00K | Dec 10 | ||
Dec 10, 2018 | SEE REMARKS | 17.40K | $5.76 | $100.22K | BUY | 70.45% | 42.10K | Dec 06 | ||
Aug 21, 2018 | PRESIDENT & CEO | 20.00K | $5.95 | $119.00K | BUY | 52.77% | 57.90K | Aug 20 | ||
Aug 15, 2018 | CHIEF FINANCIAL OFFICER | 12.50K | $6.29 | $78.63K | BUY | 260.42% | 17.30K | Aug 14 | ||
Aug 13, 2018 | PRESIDENT AND CEO | 16.90K | $6.23 | $105.29K | BUY | 80.48% | 37.90K | Aug 10 | ||
Dec 13, 2017 | PRESIDENT AND C.E.O. | 21.00K | $4.29 | $90.09K | BUY | ∞ | 21.00K | Dec 12 | ||
Dec 08, 2017 | CHIEF FINANCIAL OFFICER | 4.80K | $4.00 | $19.20K | BUY | ∞ | 4.80K | Dec 07 | ||
Dec 08, 2017 | SEE REMARKS | 24.70K | $3.93 | $97.07K | BUY | ∞ | 24.70K | Dec 06 | ||
Nov 20, 2017 | EXEC. CHAIRMAN THE BOARD | 19.00K | $5.18 | $98.42K | BUY | 2.19% | 885.78K | Nov 16 | ||
Dec 16, 2016 | PRESIDENT AND CEO | 45.30K | $7.85 | $355.61K | BUY | 5.51% | 866.78K | Dec 15 | ||
Jun 10, 2016 | PRESIDENT AND CEO | 10.00K | $6.70 | $67.00K | BUY | 1.33% | 763.13K | Jun 09 | ||
Nov 18, 2015 | PRESIDENT AND CEO | 10.00K | $8.25 | $82.50K | BUY | 1.35% | 753.13K | Nov 17 | ||
Sep 17, 2015 | CHIEF OPERATING OFFICER | -9.47K | $17.16 | -$162.51K | SELL | -7.79% | 112.06K | Sep 15 | ||
Sep 16, 2015 | PRESIDENT AND CEO | 15.00K | $16.50 | $247.46K | BUY | 2.06% | 743.13K | Sep 14 | ||
Jun 15, 2015 | 10% OWNER | -320.00K | $22.00 | -$7.04M | SELL | -96.09% | 13.01K | Jun 15 | ||
Jun 15, 2015 | DIRECTOR | -320.00K | $22.00 | -$7.04M | SELL | -96.09% | 13.01K | Jun 15 | ||
Jun 11, 2015 | 10% OWNER | -1.12M | $22.00 | -$24.62M | SELL | -94.82% | 61.08K | Jun 10 | ||
Jun 11, 2015 | 10% OWNER | -427.00K | $22.00 | -$9.39M | SELL | -96.63% | 14.88K | Jun 10 | ||
Jun 11, 2015 | DIRECTOR | -427.00K | $22.00 | -$9.39M | SELL | -96.63% | 14.88K | Jun 10 | ||
Mar 06, 2015 | SEE REMARKS | 1.00K | $13.00 | $13.00K | BUY | 1.29% | 78.65K | Jul 30 | ||
Feb 04, 2015 | 10% OWNER | -500.00K | $29.50 | -$14.75M | SELL | -96.23% | 19.59K | Feb 02 | ||
Aug 08, 2014 | 10% OWNER | 2.10M | $13.00 | $2.00M | BUY | ∞ | 2.10M | Jul 30 | ||
Jul 31, 2014 | PRESIDENT AND CEO | 330.27K | $13.00 | $999.99K | BUY | 233.38% | 471.78K | Jul 30 | ||
Jul 31, 2014 | 10% OWNER | 7.76M | $13.00 | $9.30M | BUY | ∞ | 71.38K | Jul 30 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.